18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Abroad (travel likely)RecruitingPHASE2
Conditions
Sarcoma · Small Cell Lung Cancer or Extrapulmonary Neuroendocrine Cancer (EP-NEC) · Mesothelioma · Pheochromocytoma/Paraganglioma (PPGL) · Pancreatic Ductal Adenocarcinoma · Ovarian Cancer · Hepatocellular Carcinoma · Gastric Cancer · Cholangiocarcinoma · Bladder Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (National Cancer Institute Referral Office) · ncimo_referrals@mail.nih.gov · 888-624-1937
Study leads
Esther Mena Gonzalez, M.D.
Principal Investigator
National Cancer Institute (NCI)